The Reporting Behind Theranos's Collapse

 

Bad Blood: Secrets and Lies in a Silicon Valley Startup  —  John Carreyrou

John Carreyrou's account of Theranos, the blood-testing startup that raised billions of dollars on technology that never worked as claimed, is investigative journalism of a high order, built from years of reporting and dozens of interviews with former employees who risked their careers to talk to him. The book reconstructs, in granular detail, how a fraud of that scale sustained itself for so long.

What makes the book compelling is its restraint. Carreyrou largely lets the documented events, doctored lab results, intimidated whistleblowers, a company culture built on secrecy and legal threats, speak for themselves rather than editorializing. The portrait of Elizabeth Holmes that emerges is neither a simple villain narrative nor an apology; it's a case study in how charisma, media narrative, and investor incentives can override basic technical due diligence.

The book's scope is narrow by design, focused on the mechanics of the fraud rather than broader commentary on Silicon Valley culture, which some readers may wish it addressed more directly. Within that scope, though, it's a rigorously reported and genuinely gripping account of one of the more consequential corporate frauds in recent memory.

Get Bad Blood: Secrets and Lies in a Silicon Valley Startup from Amazon